Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Corbus Pharmaceuticals Holding
CRBPCurrent price
10.79 USD
-0.4 USD (-3.57%)
Last closed
11.35 USD
Company
www.corbuspharma.com
ISIN
US21833P1030
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
173 923 264 USD
Yield for 12 month
+43.29 %
1Y
3Y
5Y
10Y
15Y
CRBP
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts. Address: 500 River Ridge Drive, Norwood, MA, United States, 02062
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
56.78 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-31 167 660 USD
Last Year
-1 487 853 USD
Current Quarter
–
Last Quarter
-200 000 USD
Key Figures CRBP
1 year
3 years
5 years
10 years
EBITDA
-45 617 700 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-28.82 %
PEG Ratio
–
Return On Equity TTM
-51.32 %
Wall Street Target Price
56.78 USD
Revenue TTM
–
Book Value
12.36 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100.00 %
Dividend Yield
–
Gross Profit TTM
-16 136 826 USD
Earnings per share
-4.71 USD
Diluted Eps TTM
-4.71 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CRBP
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History CRBP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:30
Payout Ratio
–
Last Split Date
14.02.2023
Dividend Date
–
Stock Valuation CRBP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
8.26
Price Sales TTM
163.32
Enterprise Value EBITDA
0.17
Price Book MRQ
1.16
Financials CRBP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CRBP
For 52 weeks
5.09 USD
61.90 USD
50 Day MA
17.40 USD
Shares Short Prior Month
2 401 638
200 Day MA
38.20 USD
Short Ratio
8.28
Shares Short
2 505 572
Short Percent
24.72 %
BeatStart